Kenneth R. Shroyer, MD, PhD

Professor

Medical Director of Anatomic Pathology y

 

Education:

  • Ph.D. in Experimental Pathology University of Colorado Denver (1983)

  • M.D. University of Colorado School of Medicine (1987)

 

Postdoctoral Education:

  • Intern / Resident in Pathology University of Colorado Denver (1991)

  • Board Certification (American Board of Pathology):

  • Anatomic and Clinical Pathology (1991)

  • Added Qualification in Cytopathology (1995)

Kenneth R. Shroyer, MD, PhD
Kenneth R. Shroyer, MD, PhD

 

Diagnostic Roles:

  • Vice Chair for Anatomic Pathology

  • Director of Surgical Pathology and Cytopathology

 

Teaching Roles:

  • Course Director and Lecturer, Alternate Track Pathology (MSTP, PhD students) (Lectures on Gynecologic Pathology and Molecular markers of Neoplasia)

  • Lecturer, Pathology 6000, sophomore course for medical students (Lecturer in Pathology of Uterine Cervix)

  • Director, Cytopathology Rotation for Pathology Residents, Cytology Journal Club and Cytology Didactic Series

  • Lectures presented to Pathology Residents: Molecular Biology, Gynecologic Cyto-pathology, HPV and Neoplasia

 

Research Activities:

  • Analysis of telomerase, surviving, p16 and other molecular markers of carcinoma as diagnostic adjuncts incytopathology and surgical pathology

  • Correlation of HPV detection with cytologic diagnosis, molecular markers of cell transformation, and clinical outcome in patients with premalignant lesions of the cervical mucosa.

 

Selected Publications:

  • R. Lehner, E. Jarboe, R. Gianani, S. Lucia, J.A. McGregor, A.L. Shroyer, and K. R. Shroyer. Localization of inhibitor of apoptosis protein-survivin in normal transitional cell epithelium and in carcinoma. Appl. Immunohistochem. Molec. Morphol. 10:134-138, 2002.

  • R. Lehner, T. Enomoto, J.A. McGregor, A.L. Shroyer, and K. R. Shroyer. Quantitative analysis of telomerase hTERT mRNA and telomerase activity in endometrioid adenocarcinoma and in normal endometrium. Gynecol. Oncol. 84: 120-25, 2002.

  • R. Lehner, T. Enomoto, J.A. McGregor, A.L. Shroyer, B.R. Haugen, U. Pugazhenthi, and K. R. Shroyer. Correlation of survivin mRNA detection with histologic diagnosis in normal endometrium and endometrial carcinoma. Acta Obstetricia et Gynecologica Scandinavica 81: 162-7, 2002.

  • M. Frost, E.A. Jarboe, R. Gianani, L.C. Thompson, T. Enomoto, D. Uribe-Lopez, K. R. Shroyer. Immunohistochemical localization of survivin in benign cervical mucosa, cervical dysplasia, and invasive squamous cell carcinoma. Am. J. Clin. Path. 117: 738-44, 2002.

  • L. Bonds, P. Baker, C.J. Gupp, K. R. Shroyer. Analysis of Cdc6 expression in cervical neoplasia and carcinoma. Arch. Path. Lab. Med. 126: 1163-68, 2002.

  • T. Enomoto, H. Sun, K. R. Shroyer, K. Ozaki, M. Fujita, C. Kuragaki, Y. Ueda, R. Nakashima, G. Ueda, Y. Murata. Analysis of clonality and mutations of PTEN and the K-ras genes in endometrial hyperplasia. Diag Molec Path. 11: 204-11, 2002.

  • K. R. Shroyer. Immunohistochemical markers of cell immortality. Hum. Pathol. 33: 683-85, 2002.

  • E.A. Jarboe, K.-L. Liaw, C. Thompson, D. Heinz, P. Baker, J.A. McGregor, T. Dunn, J.E. Woods, and K. R. Shroyer. Analysis of Telomerase as a Diagnostic Biomarker of Cervical Dysplasia and Carcinoma. Oncogene, 21: 664-673, 2002.

  • K. Trieb, R. Lehner, T. Stulnig, I. Sulzbacher, and K. R. Shroyer. Survivin expression in human osteosarcoma is a marker for survival. Eur. J. Surg. Oncol. 29: 379-82, 2003.

  • B.K. Kleinschmidt-DeMasters, D. Heinz, P.J. McCarthy, J.B. Bobak, K.O. Lillehei, and K. R. Shroyer. Survivin in glioblastomas: protein and mRNA expression and comparison with telomerase levels. Arch Pathol Lab Med. 127: 826-33, 2003.

  • J.E. Barrera, M. Miller, S. Said, B. Jafek, J. Campana, K. R. Shroyer. Detection of micrometastasis using immunohistochemistry of pancytokeratin in neck dissection specimens from patients with head and neck squamous cell cancer. Laryngoscope 113:892-6, 2003.

  • E.A. Jarboe, L.C. Thompson, D. Heinz, J.A. McGregor, K.R Shroyer. Telomerase and HPV as Diagnostic Adjuncts for Cervical Dysplasia and Carcinoma. Human Pathology, 35: 396-402, 2004.

  • B. Tringler, C.J. Gup, K.R. Shroyer. Correlation between p16 and pRb expression in cervical squamous and glandular neoplasia. Human Pathology, 35: 689-696, 2004.

  • B. Tringler, S Zhuo, G. Pilkington, K.C. Torkko, M. Singh, M.S. Lucia, D.E. Heinz, J. Papkoff, K.R. Shroyer. B7-H4 is highly expressed in ductal and lobular breast cancer. Clinical Cancer Research, 11: 1842-1848, 2005.

 

Office Location:

UCD-School of Medicine at Fitzsimons

12800 E. 19th Ave.

Bldg. RC-1 North, Room P18-5127

 

Contact Information:

Phone: (303) 724-3060

Fax:    (303) 724-3712

Email:  Ken.Shroyer@uchsc.edu

 

Mailing Address:

UCD-School of Medicine at Fitzsimons

Department of Pathology

Mail Stop 8104, P.O. Box 6511

Aurora, CO 80045